Diabetes :: Cloned cows to produce insulin in milk
Researchers in Argentina have moved a step closer to combating diabetes by cloning four genetically modified cows capable of producing human insulin in their milk.
Researchers in Argentina have moved a step closer to combating diabetes by cloning four genetically modified cows capable of producing human insulin in their milk.
WHO and key partners are meeting on Thursday and Friday to demonstrate an unprecedented commitment to combat the so-called neglected tropical diseases.
A new high-throughput genetic analysis technique can reveal gene markers ? by the dozens ? that determine how a patient might respond to certain cancer drugs, according to scientists at the Translational Genomics Research Institute (TGen).
A survey by Harris Interactive? found that large numbers of people believe that they are influenced by the direct to consumer advertising (DTCA) of prescription drugs. Between 21 and 51 percent agree with 10 statements about how they are influenced by DTCA, with 30 percent or more agreeing with eight of the 10 statements.
The American Australian Association (AAA) is proud to announce that Professor Ian Frazer, named Australian of the Year 2006 for his pivotal work on the human papilloma virus, will be the keynote speaker at Boston Biorelationships on Friday May 4, 2007.
Amid growing concern about the accumulation of pharmaceutical and personal care products (PPCPs) in fish and other aquatic organisms, scientists in Texas are reporting development of the first method that can screen fish for several different groups of drugs at the same time.
A new drug for the treatment of attention deficit hyperactivity disorder (ADHD) will be listed from 1 July 2007 on the Pharmaceutical Benefits Scheme (PBS).
Developing brain tumors can coax assistance from nearby cells known as microglia, according to a new study from scientists at Washington University School of Medicine in St. Louis. The researchers have identified one protein made by microglia that helps accelerate tumor growth and are looking for others.
Pharmacy benefit manager Prime Therapeutics (Prime) announced the results of a study on the utilization of Strattera(R) (atomoxetine) for treating attention deficit hyperactivity disorder (ADHD) in children.
The World Health Organization (WHO) is committed to work towards universal access, by 2010, to HIV prevention services and to treatment and care for people living with HIV/AIDS.